FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

330953008: Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5348176015 Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5348177012 Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
468232019 Betamethasone sodium phosphate+neomycin sulphate 0.1%/0.5% eye/ear/nose drops en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
468232019 Betamethasone sodium phosphate+neomycin sulphate 0.1%/0.5% eye/ear/nose drops en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
468233012 Betamethasone sodium phosphate+neomycin sulfate 0.1%/0.5% eye/ear/nose drops en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
468233012 Betamethasone sodium phosphate+neomycin sulfate 0.1%/0.5% eye/ear/nose drops en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
721038010 Betamethasone sodium phosphate+neomycin sulfate 0.1%/0.5% eye/ear/nose drops (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1192339015 Betamethasone sodium phosphate+neomycin sulfate 0.1%/0.5% eye/ear/nose drops (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1192339015 Betamethasone sodium phosphate+neomycin sulfate 0.1%/0.5% eye/ear/nose drops (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3692835012 Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear or eye or nose drops (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3692836013 Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear or eye or nose drops en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3692837016 Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear or eye or nose drops en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
5348176015 Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
5348177012 Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Is a Betamethasone+neomycin sulfate false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Betamethasone false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Corticosterone false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Adrenal hormone agent false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. anti-infectieux cutané false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Neomycin false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Bactericide false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glucocorticoid hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Local anti-infective false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Is a Betamethasone- and neomycin-containing product false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Betamethasone sodium phosphate false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Neomycin sulphate false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has manufactured dose form Ear and eye and nose drops true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has concentration strength denominator unit (attribute) Milliliter (qualifier value) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has concentration strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has concentration strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has concentration strength numerator unit mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has concentration strength numerator unit mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has concentration strength denominator unit (attribute) Milliliter (qualifier value) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Count of base of active ingredient deux false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has basis of strength substance (attribute) Neomycin sulphate false Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has precise active ingredient Neomycin sulphate false Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has precise active ingredient Betamethasone sodium phosphate false Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has basis of strength substance (attribute) Betamethasone false Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has concentration strength numerator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has concentration strength numerator value cinq false Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Is a Product containing betamethasone in ophthalmic dosage form false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Is a Product containing neomycin in ophthalmic dosage form false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Is a Product containing neomycin in otic dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Is a Product manufactured as nasal dose form (product) false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Is a Product containing only betamethasone and neomycin in ocular dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Is a Betamethasone and neomycin only product in nasal dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Is a Betamethasone and neomycin only product in otic dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Plays role Antibacterial therapeutic role (role) false Inferred relationship Existential restriction modifier (core metadata concept)
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has precise active ingredient Betamethasone sodium phosphate true Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has basis of strength substance (attribute) Betamethasone true Inferred relationship Existential restriction modifier (core metadata concept) 1
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has precise active ingredient Neomycin sulphate true Inferred relationship Existential restriction modifier (core metadata concept) 2
Betamethasone (as betamethasone sodium phosphate) 1 mg/mL and neomycin sulfate 5 mg/mL ear and eye and nose drops Has basis of strength substance (attribute) Neomycin sulphate true Inferred relationship Existential restriction modifier (core metadata concept) 2

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start